IsoRay Inc ISR:NYSE American

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/30/21 EDT
0.69quote price arrow up+0.69 (UNCH)
Volume
18,871
Close
0.6863quote price arrow down-0.0122 (-1.7466%)
Volume
381,867
52 week range
0.35 - 2.81

...

Loading . . .
  • Open0.6944
  • Day High0.7028
  • Day Low0.6811
  • Prev Close0.6863
  • 52 Week High2.81
  • 52 Week High Date01/20/21
  • 52 Week Low0.35
  • 52 Week Low Date11/20/20

Key Stats

  • Market Cap97.09M
  • Shares Out141.47M
  • 10 Day Average Volume0.71M
  • Dividend-
  • Dividend Yield-
  • Beta1.06
  • YTD % Change52.51

KEY STATS

  • Open0.6944
  • Day High0.7028
  • Day Low0.6811
  • Prev Close0.6863
  • 52 Week High2.81
  • 52 Week High Date01/20/21
  • 52 Week Low0.35
  • 52 Week Low Date11/20/20
  • Market Cap97.09M
  • Shares Out141.47M
  • 10 Day Average Volume0.71M
  • Dividend-
  • Dividend Yield-
  • Beta1.06
  • YTD % Change52.51

RATIOS/PROFITABILITY

  • EPS (TTM)-0.04
  • P/E (TTM)-15.60
  • Fwd P/E (NTM)-17.16
  • EBITDA (MRQ)-3.355M
  • ROE (MRQ)-9.52%
  • Revenue (MRQ)9.62M
  • Gross Margin (MRQ)50.36%
  • Net Margin (MRQ)-36.52%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date09/15/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On IsoRay Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
IsoRay, Inc. is a medical technology company. The Company, through its subsidiary, IsoRay Medical, Inc., develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. The Company is engaged in the production and sales of Cesium-131 (Cs-131) brachytherapy seeds. Brachytherapy seeds are small devices containing a therapeutic dose of radiation used in an interstitial radiation procedure. The brachytherapy...
Michael McCormick
Chairman
Lori Woods
Chief Executive Officer
Jennifer Streeter
Chief Operating Officer
Jonathan Hunt
Chief Financial Officer
Mark Austin
Chief Accounting Officer
Donna Fort
Vice President
Address
350 Hills St Ste 106
Richland, WA
99354-5511
United States

Top Peers

SYMBOLLASTCHG%CHG
YMTX
Yumanity Therapeutics Inc
9.08-0.36-3.81%
CNCE
Concert Pharmaceuticals Inc
3.33-0.13-3.76%
ABEO
Abeona Therapeutics Inc
1.22-0.02-1.61%
XCUR
Exicure Inc
1.35-0.01-0.74%
APVO
Aptevo Therapeutics Inc
18.77+0.10+0.54%